Averna Therapeutics is developing genomic medicines to durably and safely treat a broad range of diseases. Averna’s proprietary technology is based on a natural system and inserts therapeutic genetic instructions into “safe harbor” sites in the genome. Averna’s medicines are safe, efficient, scalable, cost-effective, and redosable.